M. T. Qaoud Et Al. , "Peroxisome Proliferator-Activated Receptors as Superior Targets for Treating Diabetic Disease, Design Strategies - Review Article," TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , vol.19, no.3, pp.353-370, 2022
Qaoud, M. T. Et Al. 2022. Peroxisome Proliferator-Activated Receptors as Superior Targets for Treating Diabetic Disease, Design Strategies - Review Article. TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , vol.19, no.3 , 353-370.
Qaoud, M. T., Almasri, I., & ÖNKOL, T., (2022). Peroxisome Proliferator-Activated Receptors as Superior Targets for Treating Diabetic Disease, Design Strategies - Review Article. TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , vol.19, no.3, 353-370.
Qaoud, Mohammed, Ihab Almasri, And TİJEN ÖNKOL. "Peroxisome Proliferator-Activated Receptors as Superior Targets for Treating Diabetic Disease, Design Strategies - Review Article," TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , vol.19, no.3, 353-370, 2022
Qaoud, Mohammed T. Et Al. "Peroxisome Proliferator-Activated Receptors as Superior Targets for Treating Diabetic Disease, Design Strategies - Review Article." TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , vol.19, no.3, pp.353-370, 2022
Qaoud, M. T. Almasri, I. And ÖNKOL, T. (2022) . "Peroxisome Proliferator-Activated Receptors as Superior Targets for Treating Diabetic Disease, Design Strategies - Review Article." TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , vol.19, no.3, pp.353-370.
@article{article, author={Mohammed T. Qaoud Et Al. }, title={Peroxisome Proliferator-Activated Receptors as Superior Targets for Treating Diabetic Disease, Design Strategies - Review Article}, journal={TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES}, year=2022, pages={353-370} }